Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,7295 USD | -4,01 % | +16,29 % | -47,89 % |
Resumen de negocios
Número de empleados: 233
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Microbiome Therapeutics
100,0
%
| 7 | 100,0 % | 126 | 100,0 % | +1.672,24 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 7 | 100,0 % | 126 | 100,0 % | +1.672,24 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 01/11/14 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 22/10/20 |
Chief Tech/Sci/R&D Officer | - | 01/05/15 | |
Kelly M. Brady
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/18 |
Marcus Chapman
COO | Chief Operating Officer | 53 | 01/03/15 |
Lisa von Moltke
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/03/20 |
Barbara McGovern
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/15 |
Matthew Henn
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/06/12 |
Carlo Tanzi
IRC | Investor Relations Contact | - | 01/10/15 |
Teresa Young
PRN | Corporate Officer/Principal | 57 | 29/06/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 01/04/15 |
Director/Board Member | 68 | 04/01/23 | |
Richard Kender
BRD | Director/Board Member | 68 | 06/10/14 |
Kurt Graves
BRD | Director/Board Member | 56 | 01/11/15 |
Paul Biondi
BRD | Director/Board Member | 54 | 20/03/20 |
Eric Shaff
CEO | Chief Executive Officer | 48 | 01/11/14 |
Willard Dere
BRD | Director/Board Member | 70 | 11/07/17 |
Stephen Berenson
CHM | Chairman | 63 | 05/08/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 151 009 462 | 142 384 021 ( 94,29 %) | 0 | 94,29 % |
Información de la empresa
Seres Therapeutics, Inc.
200 Sidney Street 4th floor
02139, Cambridge
+617 945 9626
http://www.serestherapeutics.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-47,89 % | 115 M | |
-1,51 % | 105 mil M | |
+3,22 % | 97,5 mil M | |
+1,86 % | 22,19 mil M | |
-16,53 % | 21,33 mil M | |
-8,49 % | 18,68 mil M | |
-42,33 % | 16,6 mil M | |
-20,09 % | 14,52 mil M | |
+5,47 % | 14,09 mil M | |
+28,85 % | 10,99 mil M |
- Bolsa de valores
- Acciones
- Acción MCRB
- Empresa Seres Therapeutics, Inc.